Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 AUD | -0.76% | +1.96% | +54.76% |
Mar. 26 | Race Oncology Obtains Certificate of Analysis for RC220; Shares Up Almost 6% | MT |
Mar. 18 | Race Oncology Limited(ASX:RAC) dropped from S&P/ASX All Ordinaries Index | CI |
Sales 2022 | 708K 464K | Sales 2023 | 3.13M 2.05M | Capitalization | 200M 131M |
---|---|---|---|---|---|
Net income 2022 | -11M -7.21M | Net income 2023 | -9M -5.9M | EV / Sales 2022 | 392 x |
Net cash position 2022 | 33.54M 21.98M | Net cash position 2023 | 21.52M 14.1M | EV / Sales 2023 | 56.9 x |
P/E ratio 2022 |
-26.7
x | P/E ratio 2023 |
-19.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 73.84% |
1 day | -0.76% | ||
1 week | +1.96% | ||
Current month | -8.45% | ||
1 month | -13.91% | ||
3 months | +94.03% | ||
6 months | +44.44% | ||
Current year | +54.76% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Tillett
CEO | Chief Executive Officer | - | Nov. 21 |
Chief Tech/Sci/R&D Officer | - | 23-06-30 | |
Tim Hammond
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Smith
BRD | Director/Board Member | 61 | 23-06-28 |
Borje Andersson
PRN | Corporate Officer/Principal | - | 20-01-31 |
Phillip Lynch
BRD | Director/Board Member | - | 20-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 1.3 | -0.76% | 166 369 |
24-04-26 | 1.31 | +1.55% | 55,650 |
24-04-24 | 1.29 | -1.15% | 26,149 |
24-04-23 | 1.305 | +2.35% | 44,115 |
24-04-22 | 1.275 | -6.93% | 202,589 |
Delayed Quote Australian S.E., April 29, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+54.76% | 142M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.08% | 22.15B | |
-17.37% | 21.02B | |
-8.05% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RAC Stock